Fingerprint
Dive into the research topics of 'Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10
Rebecca S. Kristeleit*, Yvette Drew, Amit M. Oza, Susan M. Domchek, Susana Banerjee, Rosalind M. Glasspool, Judith Balmaña, Lee may Chen, Manish R. Patel, Howard A. Burris, Tamar Safra, Jennifer Borrow, Kevin K. Lin, Sandra Goble, Lara Maloney, Ronnie Shapira-Frommer
*Corresponding author for this work
- University College London
- Guy's and St Thomas' NHS Foundation Trust
- Newcastle upon Tyne Hospitals NHS Foundation Trust
- Provincial Health Services Authority
- Princess Margaret Hospital
- University of Pennsylvania
- Royal Marsden NHS Foundation Trust
- Beatson Oncology Centre
- University of Glasgow
- Vall d'Hebron Institute of Oncology
- University of California at San Francisco
- Sarah Cannon Research Institute/Florida Cancer Specialists
- Sarah Cannon Research Institute
- Clovis Oncology
- Sheba Medical Center at Tel Hashomer
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations